Welcome to Iris Biotech
For better service please confirm your country and language we detected.
Thank you very much for your interest in our products. All prices listed on our website are ex-works, Germany, and may attract customs duties when imported.
You may/will be contacted by the shipping company for additional documentation that may be required by the US Customs for clearance.
We offer you the convenience of buying though a local partner, Peptide Solutions LLC who can import the shipment as well as prepay the customs duties and brokerage on your behalf and provide the convenience of a domestic sale.Continue to Iris Biotech GmbHSend request to US distributor
Published on 01/07/2021
K. Rustler, T. Bruckdorfer
Chimica Oggi2021; 39(4): 18-20
Abstract: With the approval of several COVID-19 vaccines and drugs in recent months, hope is growing that the current pandemic will end soon. However, the rise of new SARS-CoV-2 variants and the possibility of future viral pandemics means that the development of novel therapies cannot stop. Promising therapeutic approaches include repurposing the cancer drug Imatinib and herpes antivirals Penciclovir and Aciclovir, as well as the modification of arginine residues in SARS-CoV-2 proteins using methylglyoxal. Another therapeutic approach that researchers are actively investigating involves inhibitors of the main SARS-CoV-2 protease, Mpro. To facilitate the discovery of effective Mpro inhibitors, we describe two sensitive and convenient assays for rapid screening of drug candidates.
Read more: Chemistry Today journal